Skip to main content
SpringerLink
Log in

Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Antinucleosome antibodies have been found with variable prevalence in systemic lupus erythematosus (SLE) and were associated with more severe disease. This research aims to study the prevalence of antinucleosome antibodies in a sample of Brazilian adult SLE patients and their association with clinical findings and disease activity. Ninety-two adult patients (81 females and 11 males, with mean age of 37.29 ± 10.98 years) with SLE were studied for clinical and antibody profile, disease activity by SLE disease activity index (SLEDAI), and presence of antinucleosome antibodies by ELISA. The prevalence of antinucleosome antibodies was 61.9% (mean titer, 87.8 ± 62.6 U). No relationship was found of antinucleosome presence and any of the studied clinical features. A positive association was detected with anti-DNA (p = 0.001) and SLEDAI (p < 0.0001), but not with anti-Sm, anti-Ro, anti-La, and anti-RNP. No specific disease feature could be associated with the presence of antinucleosome; however, a positive relationship was detected with disease activity measured by SLEDAI and with anti-DNA presence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Giles I, Isenberg D (2007) Antinuclear antibodies: an overview. In: Hahn BH, Wallace DJ (eds) Dubois’ lupus erythematosus. Lippincott Williams & Wilkins, Philadelphia, pp 432–441

    Google Scholar 

  2. Kim H-A, Jeon J-Y, Choi G-S, Sung J-M, Kim M-J, Yun J-M et al (2008) The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans. Clin Immunol 128:277–283

    Article  PubMed  CAS  Google Scholar 

  3. Lutz CS, James JA (2007) Antibodies to spliceosomal components. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus. Lippincott Williams & Wilkins, Baltimore, pp 500–513

    Google Scholar 

  4. Gómes-Puerta JA, Burlingame RW, Cervera R (2008) Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value. Autoimmun Rev 7:606–611

    Article  Google Scholar 

  5. Düzgün N, Şahin M, Genç Y, Tutkakk H (2007) Antinucleosome antibodies. Ann N Y Acad Sci 1109:421–428

    Article  PubMed  Google Scholar 

  6. Schett G, Smolen J, Zimmermann C et al (2002) The autoimmune response to chromatin antigens in systemic lupus erythematosus. Autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity. Lupus 11:704–715

    Article  PubMed  CAS  Google Scholar 

  7. Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF et al (1994) Nucleosome restricted antibodies are detected before anti dsDNA and/or anti-histone antibodies in serum of MRL-Mp Ipr/Ipr nad +/+ mice, and are present at kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37:568–577

    Article  Google Scholar 

  8. Ravirajan CT, Rowse CTL, MacGowen JR (2001) An analysis of clinical disease activity and nephritis-associated serum antibody profiles in patients with systemic lupus erythematosus: a cross sectional study. Rheumatology 40:1405–1412

    Article  PubMed  CAS  Google Scholar 

  9. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D et al (2004) Antinucleosome antibodies in SLE: a two year follow up study of 101 patients. J Autoimmun 22:235–240

    Article  PubMed  CAS  Google Scholar 

  10. Quattrocchi P, Barrile A, Bonanno D, Giannetto L, Patafi M, Tigano V et al (2005) The role of antinucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases. Reumatismo 57:109–113

    PubMed  CAS  Google Scholar 

  11. Cervera R, Viñas O, Ramos-Casal M et al (2003) Anti-chromatin antibodies in systemic lupus erythematosus. A useful marker for lupus nephropathy. Ann Rheum Dis 62:431–434

    Article  PubMed  CAS  Google Scholar 

  12. Lahita RG (2004) The clinical presentation of systemic lupus erythematosus. In: Lahita RG (ed) Systemic lupus erythematosus. Elsevier, San Diego, pp 435–444

    Chapter  Google Scholar 

  13. Bombardier C, Gladman DD, Urowits MB, Caron D, Chan CH (1992) Derivations of SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640

    Article  PubMed  CAS  Google Scholar 

  14. Muller S, Dicker J, Tincani A, Meroni PL (2008) Pathogenic antinucleosome antibodies. Lupus 17:431–436

    Article  PubMed  CAS  Google Scholar 

  15. Ghillani-Dalbin P, Amoura Z, Cacoub P, Charuel J-L, Diemert M-C, Piette J-C et al (2003) Testing for antinucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients. Lupus 12:833–837

    Article  PubMed  CAS  Google Scholar 

  16. Campos LMA, Kiss MHB, Scheimberg MA, Mangueira CLP, Silva CA (2006) Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus. Lupus 15:496–500

    Article  PubMed  CAS  Google Scholar 

  17. Gómes-Puerta JA, Burlingame RW, Cervera R (2006) Anti-chromatin (anti-nucleosome) antibodies. Lupus 15:408–411

    Article  Google Scholar 

  18. Ferreira FGM, Skare TL, Nisihara RM, Utiyama SR (2011) Anti-nucleosome antibodies in scleroderma patients. Indian J Med Res 133:341–342

    Google Scholar 

  19. Simón JA, Rojas-Serrano J, Cabiedes J, Alcocer-Varela J (2004) Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus 13:177–181

    Article  Google Scholar 

  20. Souza A, Silva KM, Oliveira FR, Roselino AMF, Louzada P Jr (2008) Anti nucleosome and antichromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Lupus 18:223–229

    Article  Google Scholar 

Download references

Disclosures

None.

Financial source

None.

Author information

Authors and Affiliations

  1. Rheumatology Unit, Evangelical University Hospital of Curitiba, Rua João Azolin, 660, CEP 82015-040, Curitiba, Paraná, Brazil

    G. A. Sardeto, L. M. Simas, T. S. Skare & R. M. Nisihara

  2. Laboratory of Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Paraná, Brazil

    R. M. Nisihara & S. R. R. Utiyama

Authors
  1. G. A. Sardeto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Simas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. S. Skare
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. M. Nisihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. R. R. Utiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. M. Nisihara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sardeto, G.A., Simas, L.M., Skare, T.S. et al. Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population. Clin Rheumatol 31, 553–556 (2012). https://doi.org/10.1007/s10067-011-1889-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1889-9

Keywords

Search

Navigation